Group by:
Date |
Item TypeArticle
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response.
Denker, S., Bittner, A., Na, I.K., Kase, J., Frick, M., Anagnostopoulos, I., Hummel, M. and Schmitt, C.A.
International Journal of Hematologic Oncology 8
(4): IJH20.
19 December 2019
This list was generated on Sat Dec 21 18:01:06 2024 UTC.